v3.25.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
REVENUES $ 7,760 $ 5,606
COST OF REVENUES 3,490 3,706
GROSS PROFIT 4,270 1,900
OPERATING EXPENSES:    
Research and development expenses 2,383 2,702
Sales and marketing expenses 2,639 3,030
General and administrative expenses 3,169 3,531
Other Income (163)
TOTAL OPERATING EXPENSES 8,028 9,263
OPERATING LOSS (3,758) (7,363)
Interest expenses (618) (766)
Other financial income, net 2 1,843
NET COMPREHENSIVE LOSS FOR THE YEAR $ (4,374) $ (6,286)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.85) $ (2.61)
Net loss per share attributable to common shareholders – diluted (in Dollars per share) $ (0.85) $ (2.61)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 5,146,049 2,412,717
Weighted average number of common stocks used in computing net loss per share – diluted (in Shares) 5,146,049 2,412,717

Source